Literature DB >> 12657928

Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis.

Susan C Abraham1, Marcia Cruz-Correa, Pedram Argani, Emma E Furth, Ralph H Hruban, John K Boitnott.   

Abstract

Lymphoplasmacytic sclerosing pancreatitis (LPSP) represents a distinctive form of chronic pancreatitis characterized by diffuse fibroinflammatory infiltrates that can involve both the pancreatic ducts and acinar parenchyma. Several cases of inflammatory infiltrates within the gallbladder have been reported in association with LPSP, but the spectrum of gallbladder pathology in patients with LPSP has not been systematically reviewed. Many patients with LPSP have distal CBD fibrosis, strictures, and inflammation, features that overlap somewhat with primary sclerosing cholangitis (PSC). In PSC, a pattern of gallbladder pathology termed "diffuse acalculous lymphoplasmacytic chronic cholecystitis" has been previously described as showing a triad of diffuse, mucosal-based, plasma cell-rich inflammatory infiltrates. We studied 20 gallbladders from patients with LPSP and compared them with 20 gallbladders in PSC, 20 gallbladders with chronic cholelithiasis, and 10 gallbladders from patients with benign (non-LPSP) pancreatic disease. The following features were evaluated: degree and composition of mucosal inflammation and deep (mural) inflammation, lymphoid nodules, metaplasia, dysplasia/neoplasia, fibrosis, muscular hypertrophy, Rokitansky-Aschoff sinuses, and cholesterolosis. The majority (60%) of gallbladders in LPSP contained moderate or marked inflammatory infiltrates and lymphoid nodules, frequencies similar to PSC but significantly higher than in chronic cholelithiasis and benign non-LPSP pancreatic disease. LPSP gallbladders received the highest scores for deep inflammation of all groups, and 35% of LPSP gallbladders showed transmural chronic cholecystitis. Overall, "diffuse lymphoplasmacytic chronic cholecystitis" was present in 50% of PSC cases and 25% of LPSP cases, but in only 5% of chronic cholelithiasis and none of non-LPSP benign pancreatic disease. Mucosal inflammation in LPSP gallbladders correlated significantly with the presence of inflammation in the extrapancreatic portion of the CBD. These findings suggest that inflammatory pathology of the gallbladder is frequently associated with LPSP and that it is part of the spectrum of biliary tract disease in these patients, rather than a simple reflection of the pancreatitis itself.

Entities:  

Mesh:

Year:  2003        PMID: 12657928     DOI: 10.1097/00000478-200304000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

Review 1.  The Clinical and Pathological Features of IgG(4)-Related Disease.

Authors:  Arezou Khosroshahi; Vikram Deshpande; John H Stone
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

Review 2.  Autoimmune pancreatitis and IgG4-related systemic diseases.

Authors:  Lizhi Zhang; Thomas C Smyrk
Journal:  Int J Clin Exp Pathol       Date:  2010-05-25

3.  Autoimmune sclerosing pancreatitis: the surgeon's perspective.

Authors:  Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

4.  Diagnostic and treatment modalities for autoimmune pancreatitis.

Authors:  Atul S Rao; Francesco Palazzo; Joanne Chung; Eric Hager; Hamid Abdollahi; Charles J Yeo
Journal:  Curr Treat Options Gastroenterol       Date:  2006-09

5.  Sclerosing cholecystitis associated with autoimmune pancreatitis.

Authors:  Terumi Kamisawa; Yuyang Tu; Hitoshi Nakajima; Naoto Egawa; Kouji Tsuruta; Atsutake Okamoto; Shinichirou Horiguchi
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

6.  IgG4-associated cholecystitis: another clue in the diagnosis of autoimmune pancreatitis.

Authors:  Michael D Leise; Thomas C Smyrk; Naoki Takahashi; Seth R Sweetser; Santhi S Vege; Suresh T Chari
Journal:  Dig Dis Sci       Date:  2010-11-17       Impact factor: 3.199

Review 7.  Diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Itaru Naitoh; Kazuki Hayashi; Katsuyuki Miyabe; Shuya Simizu; Takashi Joh
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 8.  [Autoimmune pancreatitis].

Authors:  A Schneider; J M Löhr
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

9.  Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis.

Authors:  Takayoshi Nishino; Hiroyasu Oyama; Etsuko Hashimoto; Fumitake Toki; Itaru Oi; Makio Kobayashi; Keiko Shiratori
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

Review 10.  Autoimmune pancreatitis: histo- and immunopathological features.

Authors:  Günter Klöppel; Bence Sipos; Giuseppe Zamboni; Motohiro Kojima; Toshio Morohoshi
Journal:  J Gastroenterol       Date:  2007-05       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.